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Abstract
Considering the increased incidence of bacterial infections and the emergence of multidrug resistant bacteria at the global
level, we designed superparamagnetic iron oxide nanoparticles as nanosensors for the assessment of antimicrobial
susceptibility through magnetic relaxation. In this report, we demonstrate that iron oxide nanosensors, either dextran-
coated supplemented with Con A or silica-coated conjugated directly to Con A, can be used for the fast (1) quantification of
polysaccharides, (2) assessment of metabolic activity and (3) determination of antimicrobial susceptibility in blood. The use
of these polysaccharide nanosensors in the determination of antimicrobial susceptibility in the clinic or the field, and the
utilization of these nanoprobes in pharmaceutical R&D are anticipated.
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Introduction
In the last 20 years, there has been a dramatic increase in the
emergence of antibiotic-resistant bacteria, leading to elevated
bacterial pathogenesis at the global level [1,2]. In particular, the
emergence of drug resistant strains of Mycobacterium tuberculosis (MDR-
a n dX D R - T B )a n dt h ei n c r e a s e do c c u r r e n c eo fm e t h i c i l l i n - r e s i s t a n t
Staphylococcus aureus (MRSA) infections, indicate that drug resistance is
a major public health problem [1,2]. Recent reports indicate that in
the United States MRSA infections cause more deaths than HIV/
AIDS, whereas the development of new antibiotics has significantly
slowed down since the early 1990s [1,2,3]. Therefore, developing
sensitive and cost-efficient detection systems that can quickly identify
if (1) a particular bacterium is resistant to antibiotics, (2) the
pharmacological agents which the microorganism is susceptible to
and (3) the agents’ appropriate effective dosage is vital for successful
treatment and prevention of epidemics. Traditionally, the determi-
nation of antimicrobial susceptibility to antibiotics is facilitated after
isolation of the microorganism and examination of its growth in
media containing various antimicrobial agents, in a process that can
take up to 48 hours [4,5]. Hence, developing fast and accurate
antimicrobial susceptibility assays is important for the clinic and the
pharmaceutical industry.
Nanotechnology offers a unique alternative for the development
of detection methods for bacterial targets that require less
preparation time and smaller sample volumes, while offering
enhanced sensitivity and faster detection kinetics [6,7,8,9,10]. In
particular, nanosensors that not only detect the presence of a
particular pathogenic agent directly, but can also make an indirect
detection through the assessment of the pathogen’s metabolic
activity, e.g., via the monitoring of the rate of consumption of
nutrients in solution, would be of great utility. The development of
such nanosensors will be of significant importance, because they will
be able to interrogate whether the pathogen is still metabolically
active and reproducing in the presence of a particular antibiotic.
Currently, most contemporary nanoparticle-based immunoassays
cannot distinguish between metabolically active and dead patho-
gens [10,11]. Recently, a novel gold nanoparticle-based method for
the assessment of bacterial susceptibility via surface plasmon
resonance shifts was reported [12]. The main drawbacks of this
technique are the small, although significant, changes in the surface
plasmon band and the assay’s inability to work in turbid or opaque
media, due to the media’s strong scattering and absorbance that
mask the nanoparticles’ plasmonic band. Hence, as some
microorganisms, like Staphylococcus epidermidis and Neisseria spp.
among many others, can be present in the blood of infected
patients (septicemia), requiring isolation and growth in blood-
containing media, it is vital to have clinical diagnostic assays for the
assessment of antimicrobial susceptibility in blood [13,14].
Consequently, we reasoned that a more robust system, which
quickly determines bacterial susceptibility independent of the
solution’s optical properties, could be developed using magnetic
nanosensors and detection via water relaxation [15]. According to the
literature, it is widely acknowledged that a major benefit of using
magnetic relaxation methods is that molecular detection can be
achieved in opaque media, such as cell lysates, tissue extracts and
complex biological fluids, notably blood, with high specificity and
sensitivity [10,15,16]. Therefore, we hypothesized that bacterial-
susceptibility-monitoring nanosensors could be designed to differen-
tially respond to the presence of various concentrations of nutrients,
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amagnetic nanoparticles have been used as magnetic relaxation
sensors for the detection of various targets [10,15,16,17,18,
19,20,21,22], these nanoprobes have not been previously utilized
for the detection of metabolic activity, which might lead to the
potential development of nanosensors capable of determining
antimicrobial susceptibility in complex media. The polysaccharide
nanosensors’ clustering should result in a significant change in the
spin-spin relaxation time (T2) of the solution’s water protons,
facilitating the reliable identification of effective antimicrobial agents.
This can be achieved using dextran-coated iron oxide nanoparticles
along with a protein with high affinity to carbohydrates, such as
Concanavalin A (ConA) [23,24], in a competition assay. Specifically,
we hypothesized that upon Con A-induced clustering, the dextran-
coated iron oxide nanoparticles can differentially respond to the
polysaccharide levels associated with bacterial metabolism and
growth. Hence, the higher the rate of bacterial metabolic activity,
the fewer amount of the available polysaccharides (such as starch)
would be, resulting in prominent changes in the sample’s DT2w h e n
compared to those of the sterile medium (Figure 1).
Results
Polysaccharide quantification and bacterial metabolic
activity monitoring
In our first set of experiment, we investigated if our dextran-
coated iron oxide nanoparticles (d=,150 nm,
R2=300 mM
21s
21) were responsive to changes in starch
concentration upon bacterial growth. Initial studies in phosphate
buffered saline showed that the nanosensors quickly clustered after
addition of Con A, (Figure S1) forming stable nanoassemblies that
induced prominent changes in the T2 within an hour (Figure S2).
During initial optimization studies, we found that a Con A
concentration of 1 mg/mL and a nanoparticle solution with a
concentration of 0.02 mg Fe/mL provided optimum results (Figure
S3). Thus, we used this iron concentration in all of our
experiments. Lower iron concentrations increased the error in
the measurement, whereas higher concentrations sacrificed
sensitivity and detection kinetics, requiring higher concentrations
of Con A. Next, we assessed the capability of our nanosensors to
sense variations in MH broth’s starch concentration. In these
experiments we added our nanosensors (0.02 mg Fe/mL) to
solutions containing increasing amounts of starch in MH broth
and Con-A (1 mg/mL). We anticipated that in this competition
assay and at low concentrations of starch, the Con A would be able
to cluster the dextran-coated magnetic nanosensors resulting in
prominent changes in T2. However, as the amount of starch
increases, smaller changes in T2 are expected, as Con A would
primarily bind to starch. Results showed that after a 30-minute-
long incubation at room temperature, a dose-dependent response
curve was obtained (R
2=0.99), demonstrating that the changes in
T2 were inversely proportional to the starch concentration, in
accordance with our hypothesis (Figure 2A). Notably, the dextran-
coated polysaccharide nanosensors were able to quantify starch
Figure 1. Proposed model for the assessment of antimicrobial susceptibility using dextran-coated polysaccharide nanosensors and
Concanavalin A (ConA). In this competition assay, the dextran on the surface of the iron oxide nanoparticles and the starch in solution compete
for binding to Con A. This results in changes in the degree of Con-A induced magnetic nanoparticle clustering upon bacterial metabolic uptake of
starch.
doi:10.1371/journal.pone.0003253.g001
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concentration of a typical MH broth, to 1.5 ng/mL.
We then examined if these polysaccharide nanoprobes can
respond to changes in the starch concentration of MH broth
(initial starch concentration=77.5 ng/ml) due to bacterial meta-
bolic activity. In these experiments, magnetic nanoprobe solutions
(0.02 mg Fe/mL) containing aliquots of increasing amounts of E.
coli were incubated with Con A. Results showed that upon
addition of Con A, a dose-dependent response was observed
(R
2=0.99), after a 30-minute incubation at room temperature
(Figure 2B). The higher the bacterial population (expressed in
Colony Forming Units, CFU) the larger the changes in T2 (DT2).
This is attributed to the fact that higher bacterial populations
utilize more amounts of starch via their metabolic activities,
resulting in a concomitant reduction of the media’s carbohydrates.
As a result, addition of Con A promotes the formation of extensive
nanoassemblies, as expected. Notably, even at low bacterial
populations (10
2–10
4 CFUs) significant changes in T2 were
detected. Hence, this demonstrates the high sensitivity of the
nanosensors in detecting bacterial metabolic activity, even in the
presence of as few as 10
2 CFUs. This is of grave importance in
order to prevent septicemia, as very few bacteria in circulation
may cause systemic infection leading to death. In control
experiments we found that in the absence of Con A, the presence
of increasing amount of bacteria does not affect the T2 of the
nanoparticle solution. Specifically, all samples containing either
sterile media or different bacterial loads exhibited similar T2
values, suggesting that the presence of bacteria does not alter the
spin-spin relaxation times of the non-assembled state (Figure S4).
To further corroborate our results, we used heat-inactivated
bacteria to inhibit their metabolic activity. Consequently, nominal
differences were observed between the samples of heat-inactivated
bacteria and sterile medium (Figure S5).
Antimicrobial susceptibility assessment using dextran-
coated magnetic nanosensors
Based on our dextran-coated magnetic nanosensors’ ability to
sense carbohydrate utilization due to microbial metabolism, we
examined if these nanosensors can be used for the identification of
antimicrobial susceptibility and determination of an antibiotic’s
minimum inhibitory concentration (MIC). As MIC predicts the
success of a particular antibiotic and is an important clinical
parameter that dictates treatment in order to minimize adverse
side effects, such as renal failure, quick determination of MIC is of
paramount importance [5]. Thus, we first examined if the
presence of antibiotics in the media might induce non-specific
nanoparticle clustering, potentially interfering with the assay’s
carbohydrate specificity. In these control studies, a bacterial
population (10
6 CFU) which is typically used in MIC experiments
was incubated in the presence of different antibiotic concentra-
tions. Results showed that these culture conditions did not affect
the spin-spin relaxation times of the nanoparticle solution,
indicating absence of non-specific antibiotic-mediated nanoparti-
cle assembly (Figure S6). Subsequently, we examined if bacterial
growth and the corresponding carbohydrate uptake are affected by
the presence of a particular antibiotic. After incubating E. coli for
2 hours in the presence of ampicillin, we took 10-mL bacterial
culture aliquots in order to examine them using the dextran-
coated polysaccharide nanosensors. Thirty minutes after addition
of Con A distinct changes in the T2 were observed, indicating the
presence of two cohorts (Figure 3A upper panel). Specifically, the
starch utilization and growth of E. coli were suppressed at
ampicillin concentrations above 8 mg, as demonstrated by the
low changes in the DT2 compared to the sterile medium.
Furthermore, the nanoparticle-derived MIC of 8 mg was con-
firmed through the turbidity method, which is the current gold
standard for antimicrobial susceptibility determination (Figure 3A
lower panel). Although both assays provided identical results, the
dextran-coated polysaccharide nanosensor assay yielded faster
results with an overall time of 2.5 hours (2 hours for bacterial-
antibiotic incubation and 30 minutes for nanoparticle readout), as
opposed to 24 hours. In addition, the nanosensor-based assay
requires smaller bacterial culture volumes (10 mL) as opposed to
the turbidity MIC method (2 mL). The latter is of particular
logistics importance during epidemics and drug discovery efforts,
as it facilitates the simultaneous and cost-effective screening of
multiple samples, eliminating the need of tedious visual examina-
tion of numerous cultures.
Subsequently, we further validated the antimicrobial suscepti-
bility potential of dextran-coated polysaccharide nanosensors
Figure 2. Nanoparticle-mediated sensing of polysaccharide levels and monitoring of bacterial metabolic activity. (A) Quantification of
starch in sterile MH broth, and (B) determination of starch consumption due to bacterial metabolism in MH broth, using the dextran-coated
polysaccharide nanosensors.
doi:10.1371/journal.pone.0003253.g002
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pathogenic and Shiga-toxin producer Shigella dysenteriae, had an
ampicillin MIC of 8 mg (Figure S7). Similar to E. coli, these results
were also obtained within 2.5 hours. Then, we investigated if our
assay can determine bacterial drug resistance via the changes in
spin-spin relaxation time. As a model system, we used the hospital-
acquired pathogen Serratia marcescens [25]. This pathogen is
resistant to many antibiotics, including ampicillin, due to the
presence of resistance plasmids, and is used as a model organism
for bacterial drug resistance [26,27]. Thirty minutes after addition
of Con A into the nanoparticle solution, all samples exhibited
similar DT2 values with no statistically significant differences,
indicating that this pathogen is not susceptible to ampicillin
(Figure 3B upper panel). Confirmation of our results was achieved
via the turbidity method, where after 24 hours all cultures had a
reddish turbid appearance, due to the characteristic production of
the pigment prodigiosin by S. marcescens [28] (Figure 3B lower
panel).
Due to the fact that many bacteria can either cause septicemia
or require growth in optically turbid media, it is important to
assess bacterial susceptibility in these complex matrices. However,
most current methods cannot be utilized for the detection of
molecular targets and assessment of antimicrobial susceptibility in
blood, due to the strong absorbance and scattering from the
matrix’s constituents, including platelets and red blood cells
(Figures S8 and S9). Therefore, considering these drawbacks and
the facts that bacterial isolation is a major limitation step in
diagnosis and that certain pathogenic microorganisms require
growth in specialized media, we investigated if the dextran-coated
polysaccharide nanosensors can assess antimicrobial susceptibility
in blood. Recently, we reported the high-throughput bacterial
susceptibility determination, using the surface plasmon band shifts
of gold nanoparticles [12]. However, this method cannot be used
in opaque media, such as blood, due to the matrix’s intrinsic
optical properties, masking the nanoparticles’ plasmonic band
(Figure S8). To investigate this, we used E. coli and S. marcescens
cultures in blood-supplemented MH broth, grown in the presence
of ampicillin for 2 hours at 37uC. Aliquots of these cultures
(10 mL) were obtained and added into the dextran-coated
polysaccharide nanosensors working solution, followed by 10-mL
Con A treatment (1 mg/mL). After 45 minutes post-Con A
addition at room temperature, we determined that E. coli’s
ampicillin MIC was 8 mg (Figure 4A), without observing any
nanoparticle precipitation (Figure S10). Additionally, the S.
marcescens’ drug resistance was identified after an hour-long
incubation at 25uC (Figure 4B).
Antimicrobial susceptibility assessment using
Concanavalin A-conjugated polysaccharide nanosensors
Often times a slight modification in the nanosensors’ design
and/or the protocol followed can result in significant improve-
ments in either the sensitivity or speed of the assay [29,30].
Therefore, we hypothesized whether conjugating Con A to the
surface of the magnetic nanoparticles would allow for faster
kinetics and shorter the detection time. For these experiments, we
conjugated Con A directly to aminated silica-coated iron oxide
nanoparticles. We chose silica-coated instead of dextran-coated
iron oxide nanoparticles to avoid possible cross reaction with the
dextran on the nanoparticle’s surface. In this non-competition
assay (Figure 5), the Con A-conjugated silica coated nanosensors
would facilitate the direct sensing of the levels of carbohydrates in
solution, as opposed to the competition assay that requires two
reagents; the dextran-coated nanoparticles and the Con A for
successful sensing. The aminated silica-coated nanoparticles were
synthesized using a modified water-based synthetic protocol [31].
The resulting nanoparticles were monodispersed, having a
Figure 3. Antimicrobial susceptibility screening in MH broth with dextran-coated polysaccharide nanosensors. (A) Determination of E.
coli’s minimum inhibitory concentration in MH broth, using the changes in spin-spin relaxation times (DT2, upper panel) (Means6SE; p,0.05) and the
turbidity method (lower panel). (B) Identification of S. marcescens’ resistance to ampicillin via DT2 (upper panel, Means6SE) and the turbidity assay
(lower panel). The corresponding amount of ampicillin is indicated in the graphs and pictures of the bacterial cultures.
doi:10.1371/journal.pone.0003253.g003
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225 mM
21s
21.
In our first set of experiments with the aminated silica-coated
nanoparticles, we determined whether these nanoparticles clus-
tered non-specifically in the presence of Con A in solution. As
expected, we observed that Con A did not induce any changes in
the relaxation times of the nanoparticles (Figure S12). This
demonstrates that the silica coating on these nanoparticles lacks
any carbohydrate epitopes, rendering them suitable for the non-
competition-based sensing of carbohydrates. Therefore, we
conjugated Con A to the aminated silica-coated nanoparticles,
via carbodiimide chemistry, resulting in Con A-carrying nano-
particles with a hydrodynamic diameter of ,160 nm (Figure
S11B) (R2=225 mM
21s
21, [Con A]=0.03 mg/mL). First, we
compared the kinetic profiles of the dextran-coated nanosensors
and Con A-conjugated nanosensors using bacterial E. coli blood
cultures (10
6 CFU grown in the presence of 2 mg ampicillin).
Interestingly, we found that the non-competition assay with the
Con A-conjugated nanosensors (Figure 6, curve B) provided faster
results than the competition assay that utilizes the dextran-coated
nanosensors (Figure 6, curve A). Specifically, the competition assay
format reached its end-point after a 45-minute incubation,
whereas the non-competition assay reaches its end-point within
5 minutes upon addition of the bacterial sample. These findings
support our hypothesis of achieving faster kinetics due to the direct
conjugation of Con A to the nanoparticles.
Then, we examined if MIC determination can be achieved
using these Con A-conjugated nanosensors, in blood cultures of E.
coli and S. marcescens. Immediately upon addition of the bacterial
sample into the nanoparticle solution, distinct changes in the T2
were observed. Specifically, within 5 minutes the Con A-
nanosensors were able to determine that E. coli had an ampicillin
MIC of 8 mg (Figure 7A), in line with the data from the dextran-
coated nanosensors in the competition assay or the turbidity test.
Likewise, within 5 minutes the Con A-conjugated nanosensors
assessed that S. marcescens was resistant to ampicillin, further
corroborating the findings that the non-competition assay format
provides faster results than the competition-based assay of the
dextran-coated nanosensors (Figure 7B).
Discussion
Concluding, we have shown that superparamagnetic iron oxide
nanoparticles, either dextran-coated supplemented with Con A or
Con A-conjugated nanosensors, can be used for the quantification
of polysaccharides, assessment of metabolic activity and determi-
nation of antimicrobial susceptibility in complex matrices, such as
blood, through magnetic relaxation. This approach outperforms
optical-based assays, which cannot be utilized in opaque media.
Additionally, both iron oxide nanoparticle assay formats require
very small sample volumes, are equally reliable to gold standard
methods, and do not require any sample preparation, in contrast
to other techniques [32]. Notably though, the Con A-conjugated
polysaccharide nanosensor assay yields faster results, without
compromising sensitivity and reliability, due to faster binding
kinetics. Also, as there is no need for the addition of a second
reagent (Con A), this format might be particularly useful for point-
of-care diagnostics and applications in the field. Furthermore, the
iron oxide nanoprobes can be easily adapted for the high-
throughput screening of multiple clinical and environmental
samples, preventing epidemics and promoting drug discovery. In
view of the recent advancements in NMR technology [33,34,35],
the high-throughput and/or field analysis of multiple samples in
complex media should be feasible, even outside of the typical
laboratory setting. Overall, we believe that these assays can
expedite clinical decision-making and may facilitate the faster
discovery of potential antimicrobial agents. Further studies are in
progress to determine microbial susceptibility to antifungal and
antibacterial agents in clinical samples and other matrices.
Materials and Methods
Synthesis of iron oxide nanoparticles
Reagents. All the reagents used were of AR (Analytical
Reagent) grade. Nitrogen-purged double-distilled water was used
throughout the reaction. Iron salts, FeCl2.4H2O and FeCl3.6H2O,
were obtained from Fluka. Dextran (MW 10kDa) was received
from Amersham. TEOS: tetraethylorthosilicate (Fluka), APTS: 3-
(amino-propyl)triethoxysilane (Aldrich) and THPMP: 3-
Figure 4. Dextran-coated polysaccharide nanosensor-mediated determination antimicrobial susceptibility in blood. (A) Assessment
of E. coli’s ampicillin MIC, and (B) identification of S. marcescens’ ampicillin resistance in blood (Means6SE; p,0.05).
doi:10.1371/journal.pone.0003253.g004
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as received from the suppliers.
Procedure. The dextran-coated iron oxide nanoparticles
were prepared as previously reported in the literature [16]. The
aminated silica-coated iron oxide nanoparticles were prepared
using a previously published protocol [31], with modifications in
order to yield stable nanoparticles via a water-based synthesis.
Specifically, iron oxide nanocrystals were formed via the alkaline
precipitation method, by mixing a solution of iron salts (0.202 g
FeCl2.4H2O, 0.488 g FeCl3.6H2O, 88.7 mL HCl in 2 mL distilled
water) with an ammonium hydroxide solution (830 mlN H 4OH in
15 mL distilled water). Then, 20 seconds after the initiation of the
iron oxide nanocrystal formation, a TEOS-THPMP-APTS
solution was added (6180 mL THPMP, 2680 mL TEOS, 670 mL
APTS) under continuous vortexing. The as-synthesized
nanoparticle suspensions were centrifuged to remove large
particles. Both the amino-silica- and dextran-coated
nanoparticles were washed several times with distilled water and
concentrated through an Amicon 8200 cell (Millipore
Ultrafiltration membrane YM–30 k). Finally, the nanoparticle
suspensions were stored at 4uC until further use.
Conjugation of Concanavalin A to aminated silica-coated
iron oxide nanoparticles. Two milliliters of aminated silica-
coated iron oxide nanoparticles (R2=225 mM
21s
21,
[Fe]=0.47 mg/ml) were used for the conjugation of Con A to
the nanoparticles’ surface. Initially, in 1 mL of cold MES buffer
(0.1 M, pH 6.0) 4.8 mg EDC (Pierce) and 3 mg NHS (Pierce)
were dissolved. Then, 2 mg of lyophilized Con A (Type V, Sigma)
were dissolved in 2 mL cold MES buffer (0.1 M, pH 6.0).
Subsequently, the Con A solution was mixed with the EDC/
NHS solution, followed by a 3-minute low-speed rotary mixing at
room temperature. Finally, the aminated silica-coated iron oxide
nanoparticles were added to the Con A (amine-reactive NHS-ester
form) solution, followed by periodical rotary mixing at low speed
and storage at 4uC. The resulting Con A-conjugated silica-coated
iron oxide nanoparticles were purified from any unbound protein
via magnetic separation using an MES buffer-equilibrated (0.1 M)
LS25 MACSH column (Miltenyi Biotec).
Figure 5. Schematic representation of the assessment of antimicrobial susceptibility using Concanavalin A-conjugated
polysaccharide nanosensors. The use of silica-coated nanoparticles and the direct conjugation of Con A to the capping matrix result in a
non-competition-based assay format, which may potentially provide faster readout times.
doi:10.1371/journal.pone.0003253.g005
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Dynamic light scattering (DLS) studies were done using a
PDDLS CoolBatch 40T instrument using Precision Deconvolve
32 software. Iron concentration was determined spectrophoto-
metrically after acid digestion of the nanoparticles’ suspension,
whereas R2 relaxivity measurements were obtained using a 0.47T
mq20 NMR analyzer (Minispec, Bruker, Germany). Starch
sensing with the magnetic nanoparticles was performed using
serial dilutions of starch (,75% amylopectin, ,25% amylose, S-
516, Fisher) in non-starch containing MH broth (DIFCO
TM, BD).
The concentration of Con A conjugated to the silica-coated iron
oxide nanoparticles was determined through the BCA assay, in
accordance to the manufacturer’s protocol (Pierce), after magnetic
separation of the nanoparticle suspension using an MES buffer-
equilibrated (0.1 M) LS25 MACSH column (Miltenyi Biotec).
Bacterial cultures
In order to investigate if the dextran-coated iron oxide
nanoparticles can monitor the starch utilization due to bacterial
metabolic activity, different populations of Escherichia coli (strain
8739 from ATCC) were grown in starch-containing MH broth
(DIFCO
TM, BD) for 2 hours at 37uC. For determination of the
minimum inhibitory concentration, Escherichia coli (10
6 CFU),
Serratia marcescens (ATCC, 10
6 CFU) and Shigella sonnie (strain
9290 from ATCC, 10
6 CFU) were grown in a starch-containing
MH broth (DIFCO
TM, BD), for 2 hours at 37uC in the presence
or absence of ampicillin. For determination of MIC in blood,
bacterial stocks (10
6 CFU) were grown in the presence or absence
of ampicillin in a 5%-blood-supplemented starch-containing MH
broth, for 2 hours at 37uC. Defibrinated sheep blood was obtained
from the Colorado Serum Company, simulating bacterial isolation
and growth in typical blood agar plates. For studies requiring heat
inactivation, E. coli bacteria were autoclaved in the culture tubes
for 10 minutes. Upon incubation or inactivation, all bacterial
stocks were placed in a Fisher Isotemp freezer (Fisher Scientific,
Hampton, NH), until further use.
Sample preparation for relaxation measurements
Aliquots of 10 ml (either of the aforementioned bacteria or
media) were added into 190 ml nanoparticle working solution
(0.02 mg/mLi nC a
2+/Mg
2+-free 16 PBS for both the dextran-
coated and Con A-conjugated polysaccharide nanosensors). For
the dextran-coated polysaccharide nanosensors, 10 mL Con A
(Sigma, 1 mg/ml) were added in order to induce nanoparticle
clustering.
Measurement of proton relaxation times
Spin-spin relaxation times (T2) were measured using a 0.47 T
mq20 NMR analyzer (Minispec, Bruker, Germany). T2 values
Figure 6. Kinetic profiles of the competition and non-compe-
tition assay formats. Point A represents the end-point of the
competition assay utilizing the dextran-coated polysaccharide nano-
sensors, whereas Point B corresponds to the end-point of the non-
competition assay based on the Con A-conjugated polysaccharide
nanosensors.
doi:10.1371/journal.pone.0003253.g006
Figure 7. Antimicrobial susceptibility in blood using Con A-conjugated polysaccharide nanosensors. (A) Determination of E. coli’s
ampicillin MIC in blood, and (B) determination of Serratia marcescens’ drug resistance in blood with the Con A-conjugated polysaccharide
nanosensors, five minutes after addition of the bacterial aliquot into the nanoparticle solution (Means6SE; p,0.05).
doi:10.1371/journal.pone.0003253.g007
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through the time course of the study. For the quantification of
starch, we prepared serial dilutions of sterile starch-supplemented
MH broth (DIFCO
TM, BD) in sterile non-starch-supplemented
MH broth (DIFCO
TM, BD). Subsequently, the dextran-coated
polysaccharide nanosensors’ sensitivity and dose response to the
analyte (starch) was evaluated, by monitoring the changes in the
spin-spin relaxation time. In this case, DT2 is denoted as the
difference between the relaxation time of the solution’s initial
dispersed state before addition of the MH broth aliquot (T2in) and
the solution’s T2 after addition of the MH broth aliquot (T29).
Thus, DT2=|T292T2initial|. For all other measurements,
including E.coli’s metabolic activity monitoring via carbohydrate
quantification and magnetic relaxation-mediated antimicrobial
susceptibility assessment, DT2 is denoted as the difference between
the T2 of a sample and the corresponding sterile control sample
(DT2=|T2sample2T2control|), where the sterile control was starch-
containing MH which is used for the growth of these microor-
ganisms. The sterile control used for the nanoparticle-mediated
antimicrobial susceptibility assessment in blood was 5%-blood-
supplememted starch-containing MH broth. All experiments and
measurements were carried out in triplicate and data were
expressed as mean6standard error, unless otherwise denoted.
Response curves were obtained by fitting the data on a sigmoidal
curve, using Origin 7.5 (OriginLab, Northampton, MA). Statistical
analyses were performed on SPSS 11.5 (SPSS Inc., Chicago, IL).
Broth dilution assay for determination of Minimum
Inhibitory Concentration (MIC)
Broth dilution assay (standard method for measuring MIC) was
achieved by inoculating serial dilutions of ampicillin in sterile
starch-containing MH broth, with either E. coli, S. marcescens,o rS.
sonnei (10
6 CFU), followed by a 24-hour long incubation at 37uC.
Bacterial growth was assessed based on the broth’s turbidity,
where absence of turbidity was an indicator of successful
antimicrobial susceptibility. The lowest ampicillin concentration
where the MH broth is clear indicates the minimum concentration
of ampicillin that can successfully inhibit bacterial growth [4,5].
Supporting Information
Figure S1 Size distribution of dextran-coated polysaccharide
nanosensors (A) before addition of Con A, and (B) one hour after
Con A addition (1 mg/ml), indicating the formation of nanoparticle
clusters.
Found at: doi:10.1371/journal.pone.0003253.s001 (0.30 MB TIF)
Figure S2 Treatment with 10 ml of Con A (1 mg/ml) facilitates
the clustering of dextran-coated iron oxide nanoparticles, resulting
in prominent changes in the solution’s spin-spin relaxation time
(T2).
Found at: doi:10.1371/journal.pone.0003253.s002 (0.24 MB TIF)
Figure S3 Standard curve for determination of Con A’s
optimum concentration using a nanoparticle solution with a
concentration of 0.02 mg Fe/ml.
Found at: doi:10.1371/journal.pone.0003253.s003 (0.24 MB TIF)
Figure S4 In the absence of ConA, the IO NPs were in a non-
assembled state, exhibiting the same T2 regardless of the presence
of bacteria, after a 30-minute incubation. 1. Water, 2. Sterile
medium (with starch), 3. Sterile medium (no starch), 4.1 0
2 CFU
E. coli, 5.1 0
3 CFU E. coli, 6.1 0
4 CFU E. coli, 7.1 0
5 CFU E. coli,
8.1 0
6 CFU E. coli, 9.1 0
8 CFU E. coli, 10.1 0
9 CFU E. coli.
Found at: doi:10.1371/journal.pone.0003253.s004 (0.29 MB TIF)
Figure S5 The behavior of IO NPs is independent of the heat-
inactivated bacterial population, but it is dependent of active
bacterial metabolism. The graph depicts data obtained after a 30-
minute incubation at room temperature, in the presence of Con A.
Linear fit was applied with an R
2=0.14 (OriginPro 7.5). Similar
results were obtained after 0-, 90- and 150-minute incubations.
Found at: doi:10.1371/journal.pone.0003253.s005 (0.25 MB TIF)
Figure S6 In the absence of ConA, the IO NPs exhibited the
same T2, regardless of the presence of bacteria and antibiotic. 1.
Water, 2. Sterile medium (with starch), 3. Sterile medium (no
starch), 4.6 4mg ampicillin, 5.8mg ampicillin, 6.2mg ampicillin,
7.1mg ampicillin, 8.0mg ampicillin.
Found at: doi:10.1371/journal.pone.0003253.s006 (0.28 MB TIF)
Figure S7 Determination of the minimum inhibitory concen-
tration of Shigella sonnie using the changes in spin-spin relaxation
times (DT2) after a 30-min incubation at 25u (Means 6 SE; p
,0.05). The dotted line indicates the threshold of the drug’s
successful inhibition.
Found at: doi:10.1371/journal.pone.0003253.s007 (0.41 MB TIF)
Figure S8 UV-vis profile of a bacterial culture growing in 5%-
blood-supplemented MH broth. E. coli (10
6 CFU) were incubated
for 2 hours at 37u in the presence of 4 mg ampicillin, in 5%-blood-
supplemented starch-containing MH broth. Then, a 50-ml
bacterial culture aliquot was diluted in 950 ml1 6 PBS (Ca
2+/
Mg
2+-free), resulting in similar to the relaxation setup bacterial
aliquot dilution. The strong absorbance of blood in the visible
spectrum suggests that optical-based methods spanning from 400
to 800 nm may not be effective for MIC determination in this
matrix.
Found at: doi:10.1371/journal.pone.0003253.s008 (0.25 MB TIF)
Figure S9 Size distribution of (A) dextran-coated gold nano-
particles and (B) 5%-blood-supplemented MH broth, indicating
that the clustering of dextran-coated gold nanoparticles cannot be
used for antimicrobial susceptibility assessment in blood.
Found at: doi:10.1371/journal.pone.0003253.s009 (0.30 MB TIF)
Figure S10 Blood cultures in nanoparticle solution demonstrat-
ing the absence of nanoparticle precipitation and the optical
nature of the solution (numbers indicate the corresponding
concentration of ampicillin in mg).
Found at: doi:10.1371/journal.pone.0003253.s010 (0.36 MB TIF)
Figure S11 Size distribution of silica-IO nanoparticles (A) prior
and (B) after Con A conjugation.
Found at: doi:10.1371/journal.pone.0003253.s011 (0.29 MB TIF)
Figure S12 Absence of Con A-induced clustering in silica-coated
IO nanoparticles, indicating the lack of carbohydrate-containing
moieties on the nanoparticles’ surface.
Found at: doi:10.1371/journal.pone.0003253.s012 (0.29 MB TIF)
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